Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform

Go back to Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform
Gilead Sciences (NASDAQ: GILD) Delayed: 143.97 -0.77 (0.53%)
Previous Close $144.74    52 Week High $108.63 
Open $143.21    52 Week Low $71.39 
Day High $145.16    P/E 79.54 
Day Low $142.79    EPS $1.81 
Volume 1,754,781